iBio (IBIO) Receives NoA in Europe for Two Patents Covering Novel Protein Expression Technologies
Tweet Send to a Friend
iBio (NYSE: IBIO) received notices of intention to grant for two European patent applications claiming novel protein expression technologies.The first ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
